Abstract
Pulmonary vascular changes were studied in histological sections from 15 children and 25 adults with primary plexogenic arteriopathy. The severity of medial hypertrophy and degree of vasoconstriction were measured in histological sections and there was a close correlation between these two variables in both children and adults. More advanced arterial changes, expressed as an index of pulmonary vascular disease, were more common in adults, and their severity correlated positively with the degree of medial hypertrophy. No such correlation was found in children. There were similar numbers of plexiform lesions per square centimetre in children and adults, so that the differences in the indices of pulmonary vascular disease were mainly due to the intimal changes. Concentric laminar intimal fibrosis was more severe in adults. It is suggested that intensive spastic vasoconstriction results in the development of fibrinoid necrosis and subsequently of plexiform lesions and that this may happen irrespective of the presence of severe intimal fibrosis. This suggests that children with primary plexogenic arteriopathy in whom plexiform lesions have not yet developed are more likely to respond to vasodilator treatment than are adults in whom irreversible changes associated with intimal fibrosis have developed.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEDFORD D. E., EVANS W., SHORT D. S. Solitary pulmonary hypertension. Br Heart J. 1957 Jan;19(1):93–116. doi: 10.1136/hrt.19.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bourdillon P. D., Oakley C. M. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. doi: 10.1136/hrt.38.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daoud F. S., Reeves J. T., Kelly D. B. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol. 1978 Nov;42(5):817–822. doi: 10.1016/0002-9149(78)90102-9. [DOI] [PubMed] [Google Scholar]
- Dingemans K. P., Wagenvoort C. A. Ultrastructural study of contraction of pulmonary vascular smooth muscle cells. Lab Invest. 1976 Sep;35(3):205–212. [PubMed] [Google Scholar]
- Fujii A., Rabinovitch M., Matthews E. C. A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J. 1981 Nov;46(5):574–577. doi: 10.1136/hrt.46.5.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Honey M., Cotter L., Davies N., Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax. 1980 Apr;35(4):269–276. doi: 10.1136/thx.35.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin L. J., Peter R. H. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):69–73. doi: 10.1056/NEJM198001103020201. [DOI] [PubMed] [Google Scholar]
- Walcott G., Burchell H. B., Brown A. L., Jr Primary pulmonary hypertension. Am J Med. 1970 Jul;49(1):70–79. doi: 10.1016/s0002-9343(70)80115-2. [DOI] [PubMed] [Google Scholar]
- Yamaki S., Horiuchi T., Ishizawa E., Mohri H., Fukuda M., Tezuka F. Indication for total correction of complete transposition of the great arteries with pulmonary hypertension. J Thorac Cardiovasc Surg. 1980 Jun;79(6):890–895. [PubMed] [Google Scholar]
- Yamaki S., Tezuka F. Quantitative analysis of pulmonary vascular disease in complete transposition of the great arteries. Circulation. 1976 Nov;54(5):805–809. doi: 10.1161/01.cir.54.5.805. [DOI] [PubMed] [Google Scholar]
- Yamaki S., Wagenvoort C. A. Plexogenic pulmonary arteriopathy: significance of medial thickness with respect to advanced pulmonary vascular lesions. Am J Pathol. 1981 Oct;105(1):70–75. [PMC free article] [PubMed] [Google Scholar]